O'Shaughnessy Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Buy |
|
|||||
|
2025
Q1 | $19M | Sell |
|
|||||
|
2024
Q4 | $24.9M | Sell |
|
|||||
|
2024
Q3 | $35.1M | Buy |
|
|||||
|
2024
Q2 | $36M | Buy |
|
|||||
|
2024
Q1 | $30.6M | Buy |
|
|||||
|
2023
Q4 | $21.9M | Buy |
|
|||||
|
2023
Q3 | $18.4M | Sell |
|
|||||
|
2023
Q2 | $16.8M | Buy |
|
|||||
|
2023
Q1 | $15.6M | Buy |
|
|||||
|
2022
Q4 | $12.3M | Buy |
|
|||||
|
2022
Q3 | $7.85M | Sell |
|
|||||
|
2022
Q2 | $8.88M | Buy |
|
|||||
|
2022
Q1 | $7.39M | Buy |
|
|||||
|
2021
Q4 | $5.48M | Buy |
|
|||||
|
2021
Q3 | $3.72M | Buy |
|
|||||
|
2021
Q2 | $2.04M | Sell |
|
|||||
|
2021
Q1 | $1.77M | Buy |
|
|||||
|
2020
Q4 | $1.28M | Buy |
|
|||||
|
2020
Q3 | $1.12M | Buy |
|
|||||
|
2020
Q2 | $855K | Buy |
|
|||||
|
2020
Q1 | $191K | Sell |
|
|||||
|
2019
Q4 | $229K | Buy |
|
|||||
|
2019
Q3 | $0 | Buy |
|
|||||
|
2019
Q2 | $0 | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $310K | Sell |
|
|||||
|
2018
Q3 | $667K | Sell |
|
|||||
|
2018
Q2 | $992K | Sell |
|
|||||
|
2018
Q1 | $1.06M | Buy |
|
|||||
|
2017
Q4 | $917K | Buy |
|
|||||
|
2017
Q3 | $630K | Buy |
|
|||||
|
2017
Q2 | $202K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $7K | Sell |
|
|||||
|
2015
Q3 | $9K | Sell |
|
|||||
|
2015
Q2 | $14K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $13K | Buy |
|